Evidence map›Paper›PMID 35601184›Full record

ReviewSensors international2022

Sensing and 3D printing technologies in personalized healthcare for the management of health crises including the COVID-19 outbreak.

Ashish Kalkal, Prince Allawadhi, Pramod Kumar, Abhishek Sehgal, Ashmit Verma, Kaustubh Pawar, Rangadhar Pradhan, Biswaranjan Paital, Gopinath Packirisamy

Open access · goldAbstract readReview
In one paragraph

Review in Sensors international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ashish KalkalDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Uttarakhand, 247667, India.
Prince AllawadhiDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Uttarakhand, 247667, India.
Pramod KumarInstitute Instrumentation Center, Indian Institute of Technology Roorkee, Uttarakhand, 247667, India.
Abhishek SehgalDepartment of Chemical Engineering, Indian Institute of Technology Roorkee, Uttarakhand, 247667, India.
Ashmit VermaDivyasampark iHUB Roorkee for Devices, Materials and Technology Foundation, Indian Institute of Technology Roorkee, Uttarakhand, 247667, India.
Kaustubh PawarDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Uttarakhand, 247667, India.
Rangadhar PradhanCentre for Nanotechnology, Indian Institute of Technology Roorkee, Uttarakhand, 247667, India.
Biswaranjan PaitalRedox Regulation Laboratory, Department of Zoology, College of Basic Science and Humanities, Odisha University of Agriculture and Technology, Bhubaneswar, 751003, India.
Gopinath PackirisamyDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Uttarakhand, 247667, India.
Indian Institute of Technology Roorkee · INOdisha University of Agriculture and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A major threat that has surrounded human civilization since the beginning of the year 2020 is the outbreak of coronavirus disease 2019 (COVID-19). It has been declared a pandemic by the World Health Organization and significantly affected populations globally, causing medical and economic despair. Healthcare chains across the globe have been under grave stress owing to shortages of medical equipments necessary to address a pandemic. Furthermore, personal protective equipment supplies, mandatory for healthcare staff for treating severely ill patients, have been in short supply. To address the necessary requisites during the pandemic, several researchers, hospitals, and industries collaborated to meet the demand for these medical equipments in an economically viable manner. In this context, 3D printing technologies have provided enormous potential in creating personalized healthcare equipment, including face masks, face shields, rapid detection kits, testing swabs, biosensors, and various ventilator components. This has been made possible by capitalizing on centralized large-scale manufacturing using 3D printing and local distribution of verified and tested computer-aided design files. The primary focus of this study is, "How 3D printing is helpful in developing these equipments, and how it can be helpful in the development and deployment of various sensing and point-of-care-testing (POCTs) devices for the commercialization?" Further, the present study also takes care of patient safety by implementing novel 3D printed health equipment used for COVID-19 patients. Moreover, the study helps identify and highlight the efforts made by various organizations toward the usage of 3D printing technologies, which are helpful in combating the ongoing pandemic.

Indexed as

3D printingCOVID-19Personalized protective equipmentPoint-of-care-testing (POCTs)Sensing

Identifiers

PMID35601184
PMCPMC9107332
OpenAlexW4280536094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.